$AVNI
ARVANA INC

2022 Q3 Form 10-Q Financial Statement

#000160706222000534 Filed on August 22, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $47.17K $15.78K $8.640K
YoY Change -0.78% -10.59% -19.03%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00
YoY Change
% of Gross Profit
Operating Expenses $47.17K $15.78K $8.640K
YoY Change -0.78% -10.54% -19.03%
Operating Profit -$47.17K -$15.78K -$8.636K
YoY Change -0.77% -10.58%
Interest Expense $0.00 $393.00 -$190.00
YoY Change -100.0% -94.24% -102.26%
% of Operating Profit
Other Income/Expense, Net $14.61K -$194.00
YoY Change -96.66%
Pretax Income -$47.17K -$1.174K -$8.830K
YoY Change -99.62% -100.28% 290.71%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$47.17K -$1.174K -$8.830K
YoY Change -99.62% -100.28% 290.88%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share -$1.357K -$34.26 -$258.60
COMMON SHARES
Basic Shares Outstanding 34.15M shares 102.4M shares 102.4M shares
Diluted Shares Outstanding 102.4M shares 102.4M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $214.0K $13.20K $3.120K
YoY Change 1069950.0% -15.38% 242.86%
Cash & Equivalents $214.0K $13.20K $3.120K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $214.0K $13.20K $3.120K
YoY Change 1069970.0% -15.42% 242.86%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $214.0K $13.20K $3.120K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $214.0K $13.20K $3.120K
YoY Change 1069970.0% -15.42% 242.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $30.25K $26.56K $37.04K
YoY Change -14.32% -83.23% -89.65%
Accrued Expenses $10.10K $2.500K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $36.42K $15.80K
YoY Change -100.0% -95.42% -98.08%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $44.77K $124.8K $113.5K
YoY Change -40.04% -92.43% -94.47%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $44.77K $124.8K $113.5K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $44.77K $124.8K $113.5K
YoY Change -40.04% -92.43% -94.47%
SHAREHOLDERS EQUITY
Retained Earnings -$36.15M -$36.10M
YoY Change
Common Stock $36.32M $35.99M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $3.336K $3.336K
YoY Change
Treasury Stock Shares
Shareholders Equity $169.2K -$111.6K $110.4K
YoY Change
Total Liabilities & Shareholders Equity $214.0K $13.20K $3.120K
YoY Change 1069970.0% -15.42% 242.86%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$47.17K -$1.174K -$8.830K
YoY Change -99.62% -100.28% 290.88%
Depreciation, Depletion And Amortization $0.00
YoY Change
Cash From Operating Activities -$50.77K -$10.84K -$220.00
YoY Change 221.74% 658.04% -94.62%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions $0.00
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 251.6K 20.92K 0.000
YoY Change 125690.0% 29.7%
NET CHANGE
Cash From Operating Activities -50.77K -10.84K -220.0
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 251.6K 20.92K 0.000
Net Change In Cash 200.8K 10.08K -220.0
YoY Change -1388.9% -31.43% -94.62%
FREE CASH FLOW
Cash From Operating Activities -$50.77K -$10.84K -$220.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Central Index Key
EntityCentralIndexKey
0001113313
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-30695
dei Entity Registrant Name
EntityRegistrantName
ARVANA INC.
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0618509
dei Entity Address Address Line1
EntityAddressAddressLine1
299 S. Main Street
dei Entity Address Address Line2
EntityAddressAddressLine2
13th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
Salt Lake City
dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84111
dei City Area Code
CityAreaCode
(801)
dei Local Phone Number
LocalPhoneNumber
232-7395
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
true
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
34148518 shares
CY2022Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
13195 usd
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
3340 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
13195 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
3340 usd
CY2022Q2 us-gaap Assets
Assets
13195 usd
CY2021Q4 us-gaap Assets
Assets
3340 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
26561 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
54931 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2500 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
0 usd
CY2022Q2 us-gaap Other Loans Payable Current
OtherLoansPayableCurrent
36416 usd
CY2021Q4 us-gaap Other Loans Payable Current
OtherLoansPayableCurrent
15500 usd
CY2022Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
59307 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
34494 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
124784 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
104925 usd
CY2022Q2 us-gaap Liabilities
Liabilities
124784 usd
CY2021Q4 us-gaap Liabilities
Liabilities
104925 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34148518 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34148518 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34148518 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34148518 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
34149 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
34149 usd
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
35956574 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
35956574 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-36098976 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-36088972 usd
CY2022Q2 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
-108253 usd
CY2021Q4 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
-98249 usd
CY2022Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2085 shares
CY2021Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2085 shares
CY2022Q2 us-gaap Treasury Stock Value
TreasuryStockValue
3336 usd
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
3336 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-111589 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-101585 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13195 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3340 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10720 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3754 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16856 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7114 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
5061 usd
CY2021Q2 us-gaap Professional Fees
ProfessionalFees
13894 usd
us-gaap Professional Fees
ProfessionalFees
7561 usd
us-gaap Professional Fees
ProfessionalFees
21207 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-15781 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-17648 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-24417 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-28321 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
393 usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
6823 usd
us-gaap Interest Expense
InterestExpense
587 usd
us-gaap Interest Expense
InterestExpense
19122 usd
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
0 usd
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-14254 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
0 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
6459 usd
CY2022Q2 us-gaap Other Income
OtherIncome
15000 usd
CY2021Q2 us-gaap Other Income
OtherIncome
458833 usd
us-gaap Other Income
OtherIncome
15000 usd
us-gaap Other Income
OtherIncome
458833 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
14607 usd
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
437756 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
14413 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
446170 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1174 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
420108 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10004 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
417849 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1174 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
420108 usd
us-gaap Net Income Loss
NetIncomeLoss
-10004 usd
us-gaap Net Income Loss
NetIncomeLoss
417849 usd
CY2022Q2 avni Loss Per Common Share Basic And Diluted
LossPerCommonShareBasicAndDiluted
-0.00
CY2021Q2 avni Loss Per Common Share Basic And Diluted
LossPerCommonShareBasicAndDiluted
0.09
avni Loss Per Common Share Basic And Diluted
LossPerCommonShareBasicAndDiluted
-0.00
avni Loss Per Common Share Basic And Diluted
LossPerCommonShareBasicAndDiluted
0.09
CY2022Q2 avni Weighted Average Common Shares Outstanding Basic And Diluted
WeightedAverageCommonSharesOutstandingBasicAndDiluted
34148518 shares
CY2021Q2 avni Weighted Average Common Shares Outstanding Basic And Diluted
WeightedAverageCommonSharesOutstandingBasicAndDiluted
4610670 shares
avni Weighted Average Common Shares Outstanding Basic And Diluted
WeightedAverageCommonSharesOutstandingBasicAndDiluted
34148518 shares
avni Weighted Average Common Shares Outstanding Basic And Diluted
WeightedAverageCommonSharesOutstandingBasicAndDiluted
4610670 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-2051060 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2259 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-2053319 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
420108 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-1633211 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-101585 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-8830 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
110415 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1174 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-111589 usd
us-gaap Net Income Loss
NetIncomeLoss
-10004 usd
us-gaap Net Income Loss
NetIncomeLoss
417849 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-0 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
19122 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-0 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-4074 usd
avni Other Income Amount
OtherIncomeAmount
-0 usd
avni Other Income Amount
OtherIncomeAmount
458833 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-28370 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
42028 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2500 usd
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
24813 usd
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
8487 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11061 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5517 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Construction Loans Payable
ProceedsFromConstructionLoansPayable
20916 usd
us-gaap Proceeds From Construction Loans Payable
ProceedsFromConstructionLoansPayable
16125 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20916 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16125 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
9855 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
10608 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3340 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4994 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13195 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15602 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_841_eus-gaap--UseOfEstimates_zwhOKsnzUIxf" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86E_zKt4FcvJGbWf">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. These estimates include the recognition of deferred tax assets based on the change in unrecognized deductible temporary tax differences.</span></p>
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0 shares
CY2022Q2 us-gaap Cash
Cash
13195 usd
us-gaap Net Income Loss
NetIncomeLoss
-10004 usd
CY2022Q2 avni Working Capital Deficiency
WorkingCapitalDeficiency
111589 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0 shares
CY2021 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
29573848 shares
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
14065923 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
662251 usd
CY2021Q4 us-gaap Convertible Debt
ConvertibleDebt
107800 usd
CY2021Q4 us-gaap Other Loans Payable
OtherLoansPayable
480960 usd
CY2021Q4 us-gaap Loans Payable
LoansPayable
74762 usd
CY2021Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
149124 usd
us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.05 pure
us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2022-09-30
CY2022Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.10
us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
587 usd
CY2021Q4 avni Loan Settled Through Issuance Of Common Shares
LoanSettledThroughIssuanceOfCommonShares
50000 usd
CY2021Q4 avni Interest Settled Through Issuance Of Common Shares
InterestSettledThroughIssuanceOfCommonShares
38945 usd
CY2021Q3 avni Loans Payable To Stockholders
LoansPayableToStockholders
480960 usd
CY2021Q3 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
361283 usd
CY2021Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
89124 usd
CY2021Q3 avni Common Share Issued For Settlement Of Debt
CommonShareIssuedForSettlementOfDebt
21127123 shares
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Noncurrent
AccountsPayableAndAccruedLiabilitiesNoncurrent
262056 usd
CY2021Q3 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
6551392 shares
CY2022Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
59307 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
34494 usd
CY2021Q4 avni Loan Payable To Related Party
LoanPayableToRelatedParty
220071 usd
CY2021Q4 avni Loans Payable To Related Party
LoansPayableToRelatedParty
130947 usd
CY2021 us-gaap Interest Expense Debt
InterestExpenseDebt
89124 usd
CY2021Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
436492 shares
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
207421 usd
CY2021Q3 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
12650 usd
us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
206302 usd
CY2021Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
163586 usd

Files In Submission

Name View Source Status
0001607062-22-000534-index-headers.html Edgar Link pending
0001607062-22-000534-index.html Edgar Link pending
0001607062-22-000534.txt Edgar Link pending
0001607062-22-000534-xbrl.zip Edgar Link pending
avni-20220630.xsd Edgar Link pending
avni063022form10q.htm Edgar Link pending
ex31.htm Edgar Link pending
ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
avni-20220630_pre.xml Edgar Link unprocessable
avni-20220630_cal.xml Edgar Link unprocessable
avni063022form10q_htm.xml Edgar Link completed
avni-20220630_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
avni-20220630_def.xml Edgar Link unprocessable